Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiba Mechahougui

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Exploration of Targeted Anti-Tumor Therapy|June 30, 2025
Biliary tract cancers: advances in diagnostic and managementJames Gutmans, Hiba Mechahougui
International Journal of Molecular Sciences|February 13, 2026
Rare, Yet Targetable: New Perspectives on Ampullary CarcinomasJames Gutmans, Alex Friedlaender, Hiba Mechahougui
Revue Medicale Suisse|May 29, 2020
[Metastatic hormone-sensitive prostate cancer: more than just androgen-deprivation therapy]Hiba Mechahougui, Vérane Achard, Alex Friedlaender
Current Oncology (Toronto, Ont.)|May 26, 2023
Precision Oncology in Gastrointestinal Stromal TumorsHiba Mechahougui, Montemurro Michael, Alex Friedlaender
Revue Medicale Suisse|May 17, 2024
[Therapeutic cancer vaccines: challenges and perspectives]Gina Colarusso, Hiba Mechahougui, Assma Ben Aissa
Mediastinum (Hong Kong, China)|July 14, 2022
Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative reviewHiba Mechahougui, Harliana Yusof, Nathalie Baudoux, et al.
Cancers|August 29, 2024
Advances in Personalized OncologyHiba Mechahougui, James Gutmans, Gina Colarusso, et al.
International Journal of Molecular Sciences|May 7, 2025
BRAF Targeting Across Solid Tumors: Molecular Aspects and Clinical ApplicationsHiba Mechahougui, James Gutmans, Roumaïssa Gouasmi, et al.
Revue Medicale Suisse|December 20, 2023
[Nutritional support for individuals with advanced oncological pathology]Michaël Ghose, Laurence Genton-Graf, Hiba Mechahougui, et al.
Frontiers in Oncology|December 5, 2024
Complete response of a metastatic microsatellite-stable gastric cancer after neoadjuvant chemoimmunotherapy: should we still operate? A case report and review of the literatureHiba Mechahougui, Mickael Chevallay, François Cauchy, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Exploration of Targeted Anti-Tumor Therapy|June 30, 2025
Biliary tract cancers: advances in diagnostic and managementJames Gutmans, Hiba Mechahougui
International Journal of Molecular Sciences|February 13, 2026
Rare, Yet Targetable: New Perspectives on Ampullary CarcinomasJames Gutmans, Alex Friedlaender, Hiba Mechahougui
Revue Medicale Suisse|May 29, 2020
[Metastatic hormone-sensitive prostate cancer: more than just androgen-deprivation therapy]Hiba Mechahougui, Vérane Achard, Alex Friedlaender
Current Oncology (Toronto, Ont.)|May 26, 2023
Precision Oncology in Gastrointestinal Stromal TumorsHiba Mechahougui, Montemurro Michael, Alex Friedlaender
Revue Medicale Suisse|May 17, 2024
[Therapeutic cancer vaccines: challenges and perspectives]Gina Colarusso, Hiba Mechahougui, Assma Ben Aissa
Mediastinum (Hong Kong, China)|July 14, 2022
Home-deliverable antitumoral treatments in the age of COVID-19: the Portsmouth experience and a narrative reviewHiba Mechahougui, Harliana Yusof, Nathalie Baudoux, et al.
Cancers|August 29, 2024
Advances in Personalized OncologyHiba Mechahougui, James Gutmans, Gina Colarusso, et al.
International Journal of Molecular Sciences|May 7, 2025
BRAF Targeting Across Solid Tumors: Molecular Aspects and Clinical ApplicationsHiba Mechahougui, James Gutmans, Roumaïssa Gouasmi, et al.
Revue Medicale Suisse|December 20, 2023
[Nutritional support for individuals with advanced oncological pathology]Michaël Ghose, Laurence Genton-Graf, Hiba Mechahougui, et al.
Frontiers in Oncology|December 5, 2024
Complete response of a metastatic microsatellite-stable gastric cancer after neoadjuvant chemoimmunotherapy: should we still operate? A case report and review of the literatureHiba Mechahougui, Mickael Chevallay, François Cauchy, et al.
Pageof 2